{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-inflammation", "brain microvascular endothelial cells", "brain protection", "matrix metalloproteinase-9", "reactive oxygen species", "resveratrol"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35740292", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "29"}], "Language": ["eng"], "ELocationID": ["1270", "10.3390/biomedicines10061270"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "10", "Issue": "6", "PubDate": {"Year": "2022", "Month": "May", "Day": "29"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "Brain Protective Effect of Resveratrol via Ameliorating Interleukin-1\u03b2-Induced MMP-9-Mediated Disruption of ZO-1 Arranged Integrity.", "Abstract": {"AbstractText": ["In the central nervous system (CNS), the matrix metalloproteinase-9 (MMP-9) is induced by several factors and contributes to CNS disorders, including inflammation and neurodegeneration. Thus, the upregulation of MMP-9 has been considered to be an indicator of inflammation. Interleukin-1\u03b2 (IL-1\u03b2) is an important proinflammatory cytokine which can induce various inflammatory factors, such as MMP-9, in many inflammatory disorders. Several phytochemicals are believed to reduce the risk of several inflammatory disorders, including the CNS diseases. Among them, the resveratrol, a principal phenolic compound of the grape, blueberry, and mulberry peels and Cassia plants, has been shown to possess several medicinal properties, including antioxidative, anti-inflammatory, and antitumor function. Herein, we used mouse-brain microvascular endothelial cells (bMECs) to demonstrate the signaling mechanisms of IL-1\u03b2-induced MMP-9 expression via zymographic, RT-PCR, Western blot, reactive oxygen species (ROS) detection, immunofluorescence stain, and promoter reporter analyses. Then we evaluated the effects of resveratrol on IL-1\u03b2-induced MMP-9 expression in bMECs and its mechanism of action. We first demonstrated that IL-1\u03b2 induced MMP-9 expression in bMECs. Subsequently, IL-1\u03b2 induced MMP-9 expression via ROS-mediated c-Src-dependent transactivation of EGFR, and then activation of the ERK1/2, p38 MAPK, JNK1/2, and NF-\u03baB signaling pathway. Finally, we determined that IL-1\u03b2-induced upregulation of MMP-9 may cause the disruption of the arranged integrity of zonula occludens-1 (ZO-1), but this could be inhibited by resveratrol. These data indicated that resveratrol may have antioxidative and brain-protective activities by reducing these related pathways of ROS-mediated MMP-9 expression and tight junction disruption in brain microvascular endothelial cells."]}, "AuthorList": [{"Identifier": ["0000-0002-4495-6616"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Basic Medical Sciences, Department of Nursing, Research Center for Chinese Herbal Medicine, Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan 33303, Taiwan."}, {"Identifier": [], "Affiliation": "Department of General Surgery, New Taipei Municipal Tucheng Hospital, New Taipei 236017, Taiwan."}], "LastName": "Tsai", "ForeName": "Ming-Ming", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Chinese Internal Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan."}], "LastName": "Chen", "ForeName": "Jiun-Liang", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stroke Center and Stroke Section, Department of Neurology, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan."}], "LastName": "Lee", "ForeName": "Tsong-Hai", "Initials": "TH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science, National Taiwan Ocean University, Keelung 202301, Taiwan."}], "LastName": "Liu", "ForeName": "Hsiuming", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Bharathiar University, Coimbatore 641046, India."}], "LastName": "Shanmugam", "ForeName": "Velayuthaprabhu", "Initials": "V"}, {"Identifier": ["0000-0001-8302-2472"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Basic Medical Sciences, Department of Nursing, Research Center for Chinese Herbal Medicine, Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan 33303, Taiwan."}, {"Identifier": [], "Affiliation": "Department of Neurology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan."}], "LastName": "Hsieh", "ForeName": "Hsi-Lung", "Initials": "HL"}], "GrantList": [{"GrantID": "108-2320-B-255-002-MY3", "Agency": "Ministry of Science and Technology, Taiwan", "Country": ""}, {"GrantID": "CMRPF1L0041, CMRPF1L0021, CMRPF1I0041~2", "Agency": "Chang Gung Medical Research Foundation", "Country": ""}, {"GrantID": "ZRRPF3K0111, ZRRPF3L0091", "Agency": "Chang Gung University of Science and Technology", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Fazekas F., Gattringer T., Enzinger C. Cerebrovascular disorders. Curr. Opin. Neurol. 2018;31:345\u2013353. doi: 10.1097/WCO.0000000000000566.", "ArticleIdList": ["10.1097/WCO.0000000000000566", "29878907"]}, {"Citation": "Liu T., Wang X., Guo F., Sun X., Yuan K., Wang Q., Lan C. Lysophosphatidylcholine induces apoptosis and inflammatory damage in brain microvascular endothelial cells via GPR4-mediated NLRP3 inflammasome activation. Toxicol. Vitr. 2021;77:105227. doi: 10.1016/j.tiv.2021.105227.", "ArticleIdList": ["10.1016/j.tiv.2021.105227", "34293432"]}, {"Citation": "Griffin A.D., Turtzo L.C., Parikh G.Y., Tolpygo A., Lodato Z., Moses A.D., Nair G., Perl D.P., Edwards N.A., Dardzinski B.J., et al. Traumatic microbleeds suggest vascular injury and predict disability in traumatic brain injury. Brain. 2019;142:3550\u20133564. doi: 10.1093/brain/awz290.", "ArticleIdList": ["10.1093/brain/awz290", "PMC6821371", "31608359"]}, {"Citation": "Hu X., De Silva T.M., Chen J., Faraci F.M. Cerebral vascular disease and neurovascular injury in ischemic stroke. Circ. Res. 2017;120:449\u2013471. doi: 10.1161/CIRCRESAHA.116.308427.", "ArticleIdList": ["10.1161/CIRCRESAHA.116.308427", "PMC5313039", "28154097"]}, {"Citation": "Sweeney M.D., Sagare A.P., Zlokovic B.V. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 2018;14:133\u2013150. doi: 10.1038/nrneurol.2017.188.", "ArticleIdList": ["10.1038/nrneurol.2017.188", "PMC5829048", "29377008"]}, {"Citation": "Kumar G.P., Khanum F. Neuroprotective potential of phytochemicals. Pharmacogn. Rev. 2012;6:81\u201390. doi: 10.4103/0973-7847.99898.", "ArticleIdList": ["10.4103/0973-7847.99898", "PMC3459459", "23055633"]}, {"Citation": "Matkowski A., Jamio\u0142kowska-Kozlowska W., Nawrot I. Chinese medicinal herbs as source of antioxidant compounds where tradition meets the future. Curr. Med. Chem. 2013;20:984\u20131004.", "ArticleIdList": ["23210784"]}, {"Citation": "Zhang L.-X., Li C.-X., Kakar M.U., Khan M.S., Wu P.-F., Amir R.M., Dai D.-F., Naveed M., Li Q.-Y., Saeed M., et al. Resveratrol (RV): A pharmacological review and call for further research. Biomed. Pharmacother. 2021;143:112164. doi: 10.1016/j.biopha.2021.112164.", "ArticleIdList": ["10.1016/j.biopha.2021.112164", "34649335"]}, {"Citation": "Caruso G., Torrisi S.A., Mogavero M.P., Currenti W., Castellano S., Godos J., Ferri R., Galvano F., Leggio G.M., Grosso G., et al. Polyphenols and neuroprotection: Therapeutic implications for cognitive decline. Pharmacol. Ther. 2021;232:108013. doi: 10.1016/j.pharmthera.2021.108013.", "ArticleIdList": ["10.1016/j.pharmthera.2021.108013", "34624428"]}, {"Citation": "Kung H.C., Lin K.J., Kung C.T., Lin T.K. Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson\u2019s Disease. Biomedicines. 2021;9:918. doi: 10.3390/biomedicines9080918.", "ArticleIdList": ["10.3390/biomedicines9080918", "PMC8389563", "34440122"]}, {"Citation": "Wang D., Li S.-P., Fu J.-S., Zhang S., Bai L., Guo L. Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice. J. Neurophysiol. 2016;116:2173\u20132179. doi: 10.1152/jn.00510.2016.", "ArticleIdList": ["10.1152/jn.00510.2016", "PMC5102308", "27535376"]}, {"Citation": "Gottschall P.E., Deb S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation. 1996;3:69\u201375. doi: 10.1159/000097229.", "ArticleIdList": ["10.1159/000097229", "8945720"]}, {"Citation": "Yong V.W., Krekoski C.A., Forsyth P.A., Bell R., Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998;21:75\u201380. doi: 10.1016/S0166-2236(97)01169-7.", "ArticleIdList": ["10.1016/S0166-2236(97)01169-7", "9498303"]}, {"Citation": "Vafadari B., Salamian A., Kaczmarek L. MMP-9 in translation: From molecule to brain physiology, pathology, and therapy. J. Neurochem. 2016;139:91\u2013114. doi: 10.1111/jnc.13415.", "ArticleIdList": ["10.1111/jnc.13415", "26525923"]}, {"Citation": "Yong V.W., Power C., Forsyth P., Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2001;2:502\u2013511. doi: 10.1038/35081571.", "ArticleIdList": ["10.1038/35081571", "PMC7097548", "11433375"]}, {"Citation": "Hsieh H.-L., Yang C.-M. Role of redox signaling in neuroinflammation and neurodegenerative diseases. BioMed Res. Int. 2013;2013:484613. doi: 10.1155/2013/484613.", "ArticleIdList": ["10.1155/2013/484613", "PMC3884773", "24455696"]}, {"Citation": "Du H., Wang S. Omarigliptin Mitigates Lipopolysaccharide-Induced Neuroinflammation and Dysfunction of the Integrity of the Blood\u2013Brain Barrier. ACS Chem. Neurosci. 2020;11:4262\u20134269. doi: 10.1021/acschemneuro.0c00537.", "ArticleIdList": ["10.1021/acschemneuro.0c00537", "33237730"]}, {"Citation": "Wu C.-Y., Hsieh H.-L., Jou M.-J., Yang C.-M. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J. Neurochem. 2004;90:1477\u20131488. doi: 10.1111/j.1471-4159.2004.02682.x.", "ArticleIdList": ["10.1111/j.1471-4159.2004.02682.x", "15341531"]}, {"Citation": "Yang C.-M., Hsieh H.-L., Yu P.-H., Lin C.-C., Liu S.-W. IL-1\u03b2 Induces MMP-9-Dependent Brain Astrocytic Migration via Transactivation of PDGF Receptor/NADPH Oxidase 2-Derived Reactive Oxygen Species Signals. Mol. Neurobiol. 2015;52:303\u2013317. doi: 10.1007/s12035-014-8838-y.", "ArticleIdList": ["10.1007/s12035-014-8838-y", "25159478"]}, {"Citation": "Kamata H., Hirata H. Redox regulation of cellular signalling. Cell. Signal. 1999;11:1\u201314. doi: 10.1016/S0898-6568(98)00037-0.", "ArticleIdList": ["10.1016/S0898-6568(98)00037-0", "10206339"]}, {"Citation": "Halliwell B. Oxidative stress and neurodegeneration: Where are we now? J. Neurochem. 2006;97:1634\u20131658. doi: 10.1111/j.1471-4159.2006.03907.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.03907.x", "16805774"]}, {"Citation": "Chrissobolis S., Faraci F.M. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol. Med. 2008;14:495\u2013502. doi: 10.1016/j.molmed.2008.09.003.", "ArticleIdList": ["10.1016/j.molmed.2008.09.003", "PMC3140460", "18929509"]}, {"Citation": "Ganguly U., Kaur U., Chakrabarti S.S., Sharma P., Agrawal B.K., Saso L., Chakrabarti S. Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer\u2019s Disease. Oxid. Med. Cell Longev. 2021;2021:7086512. doi: 10.1155/2021/7086512.", "ArticleIdList": ["10.1155/2021/7086512", "PMC8068554", "33953837"]}, {"Citation": "Qin L., Liu Y., Wang T., Wei S.J., Block M.L., Wilson B., Liu B., Hong J.-S. NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia. J. Biol. Chem. 2004;279:1415\u20131421. doi: 10.1074/jbc.M307657200.", "ArticleIdList": ["10.1074/jbc.M307657200", "14578353"]}, {"Citation": "Lin C.-C., Hsieh H.-L., Shih R.-H., Chi P.-L., Cheng S.-E., Chen J.-C., Yang C.-M. NADPH oxidase 2-derived reactive oxygen species signal contributes to bradykinin-induced matrix metalloproteinase-9 expression and cell migration in brain astrocytes. Cell Commun. Signal. 2012;10:35. doi: 10.1186/1478-811X-10-35.", "ArticleIdList": ["10.1186/1478-811X-10-35", "PMC3518199", "23176293"]}, {"Citation": "Hsieh H.-L., Lin C.-C., Chan H.-J., Yang C.M., Yang C.-M. c-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cells. J. Neuroinflamm. 2012;9:152. doi: 10.1186/1742-2094-9-152.", "ArticleIdList": ["10.1186/1742-2094-9-152", "PMC3410791", "22747786"]}, {"Citation": "Simi A., Tsakiri N., Wang P., Rothwell N.J. Interleukin-1 and inflammatory neurodegeneration. Biochem. Soc. Trans. 2007;35:1122\u20131126. doi: 10.1042/BST0351122.", "ArticleIdList": ["10.1042/BST0351122", "17956293"]}, {"Citation": "Gu Y., Dee C.M., Shen J. Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Front. Biosci. (Schol. Ed.) 2011;3:1216\u20131231. doi: 10.2741/222.", "ArticleIdList": ["10.2741/222", "21622267"]}, {"Citation": "Infanger D.W., Sharma R.V., Davisson R.L. NADPH oxidases of the brain: Distribution, regulation, and function. Antioxid. Redox Signal. 2006;8:1583\u20131596. doi: 10.1089/ars.2006.8.1583.", "ArticleIdList": ["10.1089/ars.2006.8.1583", "16987013"]}, {"Citation": "Kilpatrick L.E., Hill S.J. Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies. Curr. Opin. Endocr. Metab. Res. 2021;16:102\u2013112. doi: 10.1016/j.coemr.2020.10.003.", "ArticleIdList": ["10.1016/j.coemr.2020.10.003", "PMC7960640", "33748531"]}, {"Citation": "Kaminska B., Gozdz A., Zawadzka M., Ellert-Miklaszewska A., Lipko M. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat. Rec. 2009;292:1902\u20131913. doi: 10.1002/ar.21047.", "ArticleIdList": ["10.1002/ar.21047", "19943344"]}, {"Citation": "Kaminari A., Tsilibary E.C., Tzinia A. A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer\u2019s Disease and Type 2 Diabetes Mellitus. J. Alzheimers Dis. 2018;64:1\u201316. doi: 10.3233/JAD-180035.", "ArticleIdList": ["10.3233/JAD-180035", "29865065"]}, {"Citation": "Qin W., Li J., Zhu R., Gao S., Fan J., Xia M., Zhao R.C., Zhang J. Melatonin protects blood-brain barrier integrity and permeability by inhibiting matrix metalloproteinase-9 via the NOTCH3/NF-\u03baB pathway. Aging. 2019;11:11391\u201311415. doi: 10.18632/aging.102537.", "ArticleIdList": ["10.18632/aging.102537", "PMC6932927", "31811815"]}, {"Citation": "Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia. 2002;39:279\u2013291. doi: 10.1002/glia.10108.", "ArticleIdList": ["10.1002/glia.10108", "12203394"]}, {"Citation": "Yang F., Zhao K., Zhang X., Zhang J., Xu B. ATP Induces Disruption of Tight Junction Proteins via IL-1 Beta-Dependent MMP-9 Activation of Human Blood-Brain Barrier In Vitro. Neural Plast. 2016;2016:8928530. doi: 10.1155/2016/8928530.", "ArticleIdList": ["10.1155/2016/8928530", "PMC5067334", "27795859"]}, {"Citation": "Shakibaei M., Csaki C., Nebrich S., Mobasheri A. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: Potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem. Pharmacol. 2008;76:1426\u20131439. doi: 10.1016/j.bcp.2008.05.029.", "ArticleIdList": ["10.1016/j.bcp.2008.05.029", "18606398"]}, {"Citation": "Metodiewa D., Ko\u015bka C. Reactive oxygen species and reactive nitrogen species: Relevance to cyto(neuro)toxic events and neurologic disorders. An overview. Neurotox. Res. 2000;1:197\u2013233. doi: 10.1007/BF03033290.", "ArticleIdList": ["10.1007/BF03033290", "12835102"]}, {"Citation": "Floyd R.A. Neuroinflammatory processes are important in neurodegenerative diseases: A hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 1999;26:1346\u20131355. doi: 10.1016/S0891-5849(98)00293-7.", "ArticleIdList": ["10.1016/S0891-5849(98)00293-7", "10381209"]}, {"Citation": "Kim T.Y., Leem E., Lee J.M., Kim S.R. Control of Reactive Oxygen Species for the Prevention of Parkinson\u2019s Disease: The Possible Application of Flavonoids. Antioxidants. 2020;9:583. doi: 10.3390/antiox9070583.", "ArticleIdList": ["10.3390/antiox9070583", "PMC7402123", "32635299"]}, {"Citation": "Latronico T., Bran\u00e0 M.T., Merra E., Fasano A., Di Bari G., Casalino E., Liuzzi G.M. Impact of manganese neurotoxicity on mmp-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of cns diseases. Toxicol. Sci. 2013;135:218\u2013228. doi: 10.1093/toxsci/kft146.", "ArticleIdList": ["10.1093/toxsci/kft146", "23811825"]}, {"Citation": "Bhattarai G., Poudel S.B., Kook S.-H., Lee J.-C. Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. Acta Biomater. 2016;29:398\u2013408. doi: 10.1016/j.actbio.2015.10.031.", "ArticleIdList": ["10.1016/j.actbio.2015.10.031", "26497626"]}, {"Citation": "Ma P., Yue L., Yang H., Fan Y., Bai J., Li S., Yuan J., Zhang Z., Yao C., Lin M., et al. Chondroprotective and anti-inflammatory effects of amurensin H by regulating TLR4/Syk/NF-\u03baB signals. J. Cell Mol. Med. 2020;24:1958\u20131968. doi: 10.1111/jcmm.14893.", "ArticleIdList": ["10.1111/jcmm.14893", "PMC6991675", "31876072"]}, {"Citation": "Yuan Y., Xue X., Guo R.B., Sun X.L., Hu G. Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway. CNS Neurosci. Ther. 2012;18:536\u2013546. doi: 10.1111/j.1755-5949.2012.00319.x.", "ArticleIdList": ["10.1111/j.1755-5949.2012.00319.x", "PMC6493617", "22530672"]}, {"Citation": "Leserer M., Gschwind A., Ullrich A. Epidermal growth factor receptor signal transactivation. IUBMB Life. 2000;49:405\u2013409. doi: 10.1080/152165400410254.", "ArticleIdList": ["10.1080/152165400410254", "10902572"]}, {"Citation": "Mohamed R., Janke R., Guo W., Cao Y., Zhou Y., Zheng W., Babaahmadi-Rezaei H., Xu S., Kamato D., Little P.J. GPCR transactivation signalling in vascular smooth muscle cells: Role of NADPH oxidases and reactive oxygen species. Vasc. Biol. 2019;1:R1\u2013R11. doi: 10.1530/VB-18-0004.", "ArticleIdList": ["10.1530/VB-18-0004", "PMC7439842", "32923966"]}, {"Citation": "Wan Y., Belt A., Wang Z., Voorhees J., Fisher G. Transmodulation of epidermal growth factor receptor mediates IL-1 beta-induced MMP-1 expression in cultured human keratinocytes. Int. J. Mol. Med. 2001;7:329\u2013334.", "ArticleIdList": ["11179516"]}, {"Citation": "Mechelke T., Wittig F., Ramer R., Hinz B. Interleukin-1beta Induces Tissue Factor Expression in A549 Cells via EGFR-Dependent and -Independent Mechanisms. Int. J. Mol. Sci. 2021;22:6606. doi: 10.3390/ijms22126606.", "ArticleIdList": ["10.3390/ijms22126606", "PMC8235322", "34205482"]}, {"Citation": "Griendling K.K., Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul. Pept. 2000;91:21\u201327. doi: 10.1016/S0167-0115(00)00136-1.", "ArticleIdList": ["10.1016/S0167-0115(00)00136-1", "10967199"]}, {"Citation": "Chiu L.Y., Wu N.L., Hung C.F., Bai P., Dai Y.S., Lin W.W. PARP-1 involves in UVB-induced inflammatory response in keratinocytes and skin injury via regulation of ROS-dependent EGFR transactivation and p38 signaling. FASEB J. 2021;35:e21393. doi: 10.1096/fj.202002285RR.", "ArticleIdList": ["10.1096/fj.202002285RR", "33570794"]}, {"Citation": "Zhou J., Du T., Li B., Rong Y., Verkhratsky A., Peng L. Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion. ASN Neuro. 2015;7:1759091415602463. doi: 10.1177/1759091415602463.", "ArticleIdList": ["10.1177/1759091415602463", "PMC4601130", "26442853"]}, {"Citation": "Zheng Y., Han Z., Zhao H., Luo Y. MAPK: A Key Player in the Development and Progression of Stroke. CNS Neurol. Disord. Drug Targets. 2020;19:248\u2013256. doi: 10.2174/1871527319666200613223018.", "ArticleIdList": ["10.2174/1871527319666200613223018", "32533818"]}, {"Citation": "Liu Z., Yao X., Jiang W., Li W., Zhu S., Liao C., Zou L., Ding R., Chen J. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-\u03baB signaling pathway and pyroptosis after secondary spinal cord injury. J. Neuroinflamm. 2020;17:90. doi: 10.1186/s12974-020-01751-2.", "ArticleIdList": ["10.1186/s12974-020-01751-2", "PMC7082940", "32192500"]}, {"Citation": "Tong W., Chen X., Song X., Chen Y., Jia R., Zou Y., Li L., Yin L., He C., Liang X., et al. Resveratrol inhibits LPS-induced inflammation through suppressing the signaling cascades of TLR4-NF-kappaB/MAPKs/IRF3. Exp. Ther. Med. 2020;19:1824\u20131834.", "ArticleIdList": ["PMC7027153", "32104238"]}, {"Citation": "Haddad J.J. Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology. Cytokines Cell. Mol. Ther. 2002;7:1\u201314. doi: 10.1080/13684730216401.", "ArticleIdList": ["10.1080/13684730216401", "12171246"]}, {"Citation": "Shao A.-W., Wu H.-J., Chen S., Ammar A.-B., Zhang J.-M., Hong Y. resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-\u03baB-dependent inflammatory/MMP-9 pathway. CNS Neurosci. Ther. 2014;20:182\u2013185. doi: 10.1111/cns.12194.", "ArticleIdList": ["10.1111/cns.12194", "PMC6493158", "24279692"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "3"}, {"Year": "2022", "Month": "5", "Day": "23"}, {"Year": "2022", "Month": "5", "Day": "27"}, {"Year": "2022", "Month": "6", "Day": "24", "Hour": "1", "Minute": "5"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "5", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35740292", "PMC9219827", "10.3390/biomedicines10061270", "biomedicines10061270"]}}], "PubmedBookArticle": []}